| abstract |
The present invention relates to tricyclic 2-pyridone compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable forms thereof, for use as HIV reverse transcriptase inhibitors, and to pharmaceutical compositions and diagnostic kits thereof, and procedures for using a kit for the treatment of a viral infection or as a standard for an assay or reagent.ŕ |